Companies News Today highlights: Stay ahead of the curve with the latest insights from the corporate world through our company news coverage. This section provides a detailed look at significant events affecting industries and markets globally, including mergers, acquisitions, financial reports, and strategic shifts in leadership and operations. Whether you're an investor, a business professional, or simply interested in the dynamics of various industries, our reports offer a deep dive into the developments that shape the economic landscape. From startups to established giants, we bring you the news that matters to help you make informed decisions in a rapidly changing business environment.
Disclaimer: This is an AI-generated live blog and has not been edited by LiveMint staff.
Company Business News Today Live: Arvinder Singh Sahney appointed Indian Oil CMD
- In his previous role, Sahney headed the petrochemicals division of the company. He succeeded V. Satish Kumar, the director (marketing) who was handling the additional charge of CMD since 1 September.
Company News Today Live: BII, Norfund, IndiGrid form a $300 mn business for greenfield transmission and BESS projects
- BII and Norfund will provide access to capital from global development financial institutions and the Norwegian private pension fund.
Company News Today Live: IPO-bound NTPC Green Energy targets investments worth ₹1 lakh crore in wind, solar assets by FY27
- IPO-bound NTPC Green Energy targets investments worth ₹1 lakh crore in wind, solar assets by FY27
Company News Today Live: Land, power and skill: Inside the high-stakes battle to build the next Foxconn City
- Foxconn has already invested $10 billion in India. Now, it wants to expand and establish large campuses. Apart from factories, these mini-cities would host residential facilities, recreational areas, hospitals and schools. Four Indian states are eyeing this investment.
Company Results Today Live: AstraZeneca Q2 net profit declines 10%, revenue up 31%
- AstraZeneca’s growth was driven by its portfolio of products in the oncology, biopharmaceuticals and rare disease segments